达安基因：授权管理层出售不超公司总股本的3%

Core Viewpoint - The company, Da An Gene (002030.SZ), has announced a plan to authorize its management to sell a portion of its stock assets to optimize its asset structure and improve liquidity and operational efficiency [1] Summary by Sections Authorization Details - The board of directors will hold a meeting on October 29, 2025, to review and approve the proposal for stock asset sales [1] - The authorization period is set for 12 months from the date of approval by the board [1] Stock Reduction Limits - The total number of shares to be reduced through centralized bidding will not exceed 1% of the company's total share capital [1] - The total number of shares to be reduced through block trading will not exceed 2% of the company's total share capital [1]